Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

68.20 +0.02 (+0.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops
Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be... 
Via StockStory
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
From DexCom, Inc.
Via Business Wire
What Does the Market Think About DexCom Inc?
 
Via Benzinga
Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. and Certain Officers – DXCM
From Pomerantz LLP
Via GlobeNewswire
Earnings Scheduled For October 30, 2025
 
Via Benzinga
An Overview of DexCom's Earnings
 
Via Benzinga
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
Should You Buy DexCom Stock Before Oct. 31?
The company hasn't had a great year. Is it about to turn things around? 
Via The Motley Fool
Topics Lawsuit
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DexCom (DXCM) Reports Earnings Tomorrow: What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know. 
Via StockStory
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors
From Kirby McInerney LLP
Via Business Wire
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify. 
Via Benzinga
Topics Death Lawsuit
Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices
Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 
Via Stocktwits
Topics Death Economy
Dexcom Appoints Euan Ashley to Board of Directors
From DexCom, Inc.
Via Business Wire
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Forecasting The Future: 13 Analyst Projections For DexCom
 
Via Benzinga
2 Stocks Down 17% and 21% to Buy Right Now
Both companies have faced recent challenges, but look likely to overcome them. 
Via The Motley Fool
Topics World Trade
Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment
Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
Dexcom Inc (NASDAQ:DXCM) Fits the Affordable Growth Strategy with Solid Expansion and Sensible Pricing
Dexcom offers strong growth in diabetes care with solid profitability and a reasonable valuation, fitting an affordable growth investment strategy. 
Via Chartmill
DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. 
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Friday.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Forecasting The Future: 10 Analyst Projections For DexCom
10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. 
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.